NEWS
- Stem Cell Therapy Successful In Treatment of Type 1 Diabetes
- Lipid Nanoparticles: mRNA Therapies' Golden Partner
- ADC Drugs with New Targets Clinical Pipeline Review
- FDA Approves Tivdak - First Tissue Factor (TF)-Targeted Antibody Conjugate Drug (ADC)
- Global Antibody-drug Conjugates (ADCs): Approvals & Clinical Trails Review
- The History Of ADC Drugs Development
- FDA Approved Antibody-Drug Conjugates Up To 2021
- Nano Drugs: Let The Blood-Brain Barrier No Longer Be A "Barrier"
- COVID-19 mRNA Vaccine Excipients - PEG Products Supply
- Lipid Nanoparticles for Drug and Vaccine Delivery